IMCR logo

Immunocore Holdings (IMCR) EBIT

annual EBIT:

-$34.09M+$21.64M(+38.83%)
December 31, 2024

Summary

  • As of today (June 27, 2025), IMCR annual earnings before interest & taxes is -$34.09 million, with the most recent change of +$21.64 million (+38.83%) on December 31, 2024.
  • During the last 3 years, IMCR annual EBIT has risen by +$140.21 million (+80.44%).
  • IMCR annual EBIT is now at all-time high.

Performance

IMCR EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

quarterly EBIT:

$9.11M+$25.55M(+155.41%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR quarterly earnings before interest & taxes is $9.11 million, with the most recent change of +$25.55 million (+155.41%) on March 31, 2025.
  • Over the past year, IMCR quarterly EBIT has increased by +$29.95 million (+143.71%).
  • IMCR quarterly EBIT is now -7.73% below its all-time high of $9.87 million, reached on September 30, 2024.

Performance

IMCR quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

TTM EBIT:

-$3.83M+$29.95M(+88.67%)
March 31, 2025

Summary

  • As of today (June 27, 2025), IMCR TTM earnings before interest & taxes is -$3.83 million, with the most recent change of +$29.95 million (+88.67%) on March 31, 2025.
  • Over the past year, IMCR TTM EBIT has increased by +$54.84 million (+93.48%).
  • IMCR TTM EBIT is now at all-time high.

Performance

IMCR TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

IMCR EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.8%+143.7%+93.5%
3 y3 years+80.4%+142.2%+97.5%
5 y5 years+78.8%+135.1%+94.7%

IMCR EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+80.4%-7.7%+137.4%at high+97.5%
5 y5-yearat high+80.4%-7.7%+119.1%at high+97.8%
alltimeall timeat high+80.4%-7.7%+119.1%at high+97.8%

IMCR EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$9.11M(-155.4%)
-$3.83M(-88.7%)
Dec 2024
-$34.09M(-38.8%)
-$16.44M(-266.5%)
-$33.77M(-18.9%)
Sep 2024
-
$9.87M(-255.1%)
-$41.67M(-15.8%)
Jun 2024
-
-$6.37M(-69.5%)
-$49.49M(-15.7%)
Mar 2024
-
-$20.84M(-14.4%)
-$58.67M(+5.3%)
Dec 2023
-$55.74M(+57.1%)
-$24.33M(-1285.8%)
-$55.73M(+15.2%)
Sep 2023
-
$2.05M(-113.2%)
-$48.39M(+12.8%)
Jun 2023
-
-$15.55M(-13.2%)
-$42.88M(+20.2%)
Mar 2023
-
-$17.91M(+5.4%)
-$35.67M(-9.4%)
Dec 2022
-$35.47M
-$16.99M(-324.7%)
-$39.37M(-40.4%)
Sep 2022
-
$7.56M(-190.6%)
-$66.07M(-42.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$8.34M(-61.4%)
-$115.17M(-25.5%)
Mar 2022
-
-$21.61M(-50.5%)
-$154.56M(-12.6%)
Dec 2021
-$174.31M(+51.8%)
-$43.68M(+5.1%)
-$176.74M(+7.0%)
Sep 2021
-
-$41.55M(-13.0%)
-$165.14M(+7.8%)
Jun 2021
-
-$47.73M(+9.0%)
-$153.25M(+17.5%)
Mar 2021
-
-$43.79M(+36.5%)
-$130.47M(+15.8%)
Dec 2020
-$114.82M(-28.5%)
-$32.07M(+8.2%)
-$112.66M(-11.1%)
Sep 2020
-
-$29.65M(+18.8%)
-$126.75M(+30.5%)
Jun 2020
-
-$24.95M(-3.9%)
-$97.10M(+34.6%)
Mar 2020
-
-$25.98M(-43.7%)
-$72.14M(+56.3%)
Dec 2019
-$160.48M(+44.8%)
-$46.16M
-$46.16M
Dec 2018
-$110.82M
-
-

FAQ

  • What is Immunocore Holdings annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Immunocore Holdings?
  • What is Immunocore Holdings annual EBIT year-on-year change?
  • What is Immunocore Holdings quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Immunocore Holdings?
  • What is Immunocore Holdings quarterly EBIT year-on-year change?
  • What is Immunocore Holdings TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Immunocore Holdings?
  • What is Immunocore Holdings TTM EBIT year-on-year change?

What is Immunocore Holdings annual earnings before interest & taxes?

The current annual EBIT of IMCR is -$34.09M

What is the all time high annual EBIT for Immunocore Holdings?

Immunocore Holdings all-time high annual earnings before interest & taxes is -$34.09M

What is Immunocore Holdings annual EBIT year-on-year change?

Over the past year, IMCR annual earnings before interest & taxes has changed by +$21.64M (+38.83%)

What is Immunocore Holdings quarterly earnings before interest & taxes?

The current quarterly EBIT of IMCR is $9.11M

What is the all time high quarterly EBIT for Immunocore Holdings?

Immunocore Holdings all-time high quarterly earnings before interest & taxes is $9.87M

What is Immunocore Holdings quarterly EBIT year-on-year change?

Over the past year, IMCR quarterly earnings before interest & taxes has changed by +$29.95M (+143.71%)

What is Immunocore Holdings TTM earnings before interest & taxes?

The current TTM EBIT of IMCR is -$3.83M

What is the all time high TTM EBIT for Immunocore Holdings?

Immunocore Holdings all-time high TTM earnings before interest & taxes is -$3.83M

What is Immunocore Holdings TTM EBIT year-on-year change?

Over the past year, IMCR TTM earnings before interest & taxes has changed by +$54.84M (+93.48%)
On this page